Prognostic factors for lymph node metastasis from advanced squamous cell carcinoma of the skin of the trunk and extremities

Vinicius de Lima Vazquez¹ , Teoclito Sachetto² , Natalia Martins Perpetuo¹ and Andre Lopes Carvalho¹

¹Department of Surgery, Hospital de Cancer de Barretos, Rua Antenor Duarte Villela, 1331 Barretos – SP, 14784-400, Brazil

²Department of pathology, Hospital de Cancer de Barretos, Rua Antenor Duarte Villela, 1331 Barretos – SP, 14784-400, Brazil

author email corresponding author email

World Journal of Surgical Oncology 2008, 6:73doi:10.1186/1477-7819-6-73


Published:	4 July 2008

Abstract

Background

Squamous cell carcinoma (SCC) of the skin of the trunk and extremities may present lymph node metastasis with difficult disease control and poor survival. The purpose of this study was to identify risk factors for lymph node metastasis and outcome.

Patients/Methods

Retrospective review of 57 patients with locally advanced SCC of the trunk and extremities was performed and several clinical variables including age, gender, ethnicity, previously injured skin (burns, scars, ulcers and others), patient origin (rural or urban), anatomic site and treatment were studied.

Results

Fifteen patients presented with previous skin lesions. Thirty-six were classified as T3 tumors and 21 as T4; 46 were N0, and 11, N1. Eleven N0 patients presented lymph node metastasis during follow up. Univariate analysis identified previous skin lesions (ulcers and scars) as risk factor for lymph node metastasis (p = 0.047). Better survival was demonstrated for T3 (p = 0.018) classification. N0 patients who presented lymph node metastasis during follow up (submitted to lymphadenectomy) had similar survival to patients without lymph node recurrence (p = 0.219).

Conclusion

Local advanced tumors are at risk of lymph node metastasis. Increased risk is associated to previous lesions at tumor site. T4 classification have worse prognosis. Lymph node recurrences in N0 patients, once treated, did not affect survival. For these patients, we propose close follow up and prompt treatment of lymph node metastasis. These results do not support indication for elective lymphadenectomy or sentinel node mapping. Further prospective studies must address this issue.